COARTEM (Novartis Pharmaceuticals Corporation)
Welcome to the PulseAid listing for the COARTEM drug offered from Novartis Pharmaceuticals Corporation. This Antimalarial [EPC],Antimalarial [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Novartis Pharmaceuticals Corporation |
| NON-PROPRIETARY NAME: | artemether and lumefantrine |
| SUBSTANCE NAME: | ARTEMETHER; LUMEFANTRINE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Antimalarial [EPC],Antimalarial [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2009-04-07 |
| END MARKETING DATE: | 0000-00-00 |
COARTEM HUMAN PRESCRIPTION DRUG Details:
| Item Description | COARTEM from Novartis Pharmaceuticals Corporation |
| LABELER NAME: | Novartis Pharmaceuticals Corporation |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 20; 120(mg/1; mg/1) |
| START MARKETING DATE: | 2009-04-07 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0078-0568_bb71743d-1ef1-4a63-b6f3-6695494a6112 |
| PRODUCT NDC: | 0078-0568 |
| APPLICATION NUMBER: | NDA022268 |
Other ARTEMETHER; LUMEFANTRINE Pharmaceutical Manufacturers / Labelers:
